Report
SARTORIUS AG : Takeover of Polyplus sensible, but not cheap
>Acquisition of Polyplus expands exposure towards viral vectors - Sartorius Stedim announced the acquisition of Polyplus for c. € 2.4bn. Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. It develops and produces transfection as well as other DNA/RNA delivery reagents and plasmid DNA in high quality and GMP grade. These are key components in the production of viral vectors use...
Underlying
Sartorius AG Pref
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Oliver Metzger
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.